This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Philippe Parone
Director, Industrialization at Celyad, Belgium


Philippe Parone, Ph.D., is the Director for Industrialization at Celyad. Prior to Celyad, Dr. Parone worked at Fate Therapeutics overseeing the development of cell therapy product candidates derived from hematopoietic stem cells and iPSCs for the treatment of autoimmune disorders. During his time at Fate therapeutics, Dr. Parone was part of the team that filed the INDs for the first U.S. clinical investigation of an iPSC-derived cell product and the world’s first cell therapy derived from an engineered iPSC. Dr. Parone holds a PhD in Biochemistry and Cell biology from the University of Cambridge and received his B.S. in Biology from the University of East Anglia.

Agenda Sessions

  • Non-Gene Edited Approaches to Allogeneic CAR-T Cell Therapy